Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -25.95%121.93K | -40.66%142.49K | 148.61%175.52K | 210.29%640.57K | 155.70%165.19K | 158.78%164.67K | 322.73%240.11K | 229.84%70.6K | 206.44K | 64.6K |
| Operating revenue | -25.95%121.93K | -40.66%142.49K | 148.61%175.52K | 210.29%640.57K | 155.70%165.19K | 158.78%164.67K | 322.73%240.11K | 229.84%70.6K | --206.44K | --64.6K |
| Cost of revenue | -43.71%114.13K | -136.69%-52.29K | 223.31K | 572.55K | 227.26K | 202.77K | 142.52K | 0 | 0 | 0 |
| Gross profit | 120.47%7.8K | 99.59%194.78K | -167.69%-47.79K | -67.05%68.02K | -196.08%-62.07K | -159.87%-38.1K | 71.81%97.59K | 70.6K | 206.44K | 64.6K |
| Operating expense | 78.13%2.63M | 48.49%2.15M | 12.90%1.74M | 1.72%6.74M | 23.75%2.27M | -1.73%1.47M | -10.32%1.45M | -7.74%1.54M | -18.41%6.62M | -23.97%1.83M |
| Selling and administrative expenses | 99.90%2.3M | 60.31%1.83M | 15.86%1.42M | 15.25%5.44M | 32.40%1.94M | 10.10%1.15M | 1.99%1.14M | 11.94%1.22M | -13.56%4.72M | -5.83%1.47M |
| -Selling and marketing expense | 50.65%156.74K | 21.46%115.13K | 37.84%146.88K | ---- | ---- | 47.90%104.04K | 48.50%94.79K | 43.64%106.56K | -48.73%312.4K | 2.27%104.04K |
| -General and administrative expense | 104.79%2.15M | 63.83%1.71M | 13.76%1.27M | 15.25%5.44M | 34.16%2.25M | 7.37%1.05M | -0.83%1.05M | 9.63%1.12M | -2.71%4.72M | 15.06%1.68M |
| Research and development costs | ---- | ---- | ---- | --0 | --0 | --0 | --0 | --0 | -50.62%778.19K | -94.57%30.75K |
| Depreciation amortization depletion | 0.37%323.57K | 2.25%328.05K | 1.60%325.39K | 15.31%1.29M | -2.61%328.37K | 15.18%322.37K | 27.28%320.84K | 27.52%320.27K | 4.12%1.12M | 16.42%337.17K |
| -Depreciation and amortization | 0.37%323.57K | 2.25%328.05K | 1.60%325.39K | 15.31%1.29M | -2.61%328.37K | 15.18%322.37K | 27.28%320.84K | 27.52%320.27K | 4.12%1.12M | 16.42%337.17K |
| Other taxes | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Other operating expenses | ---- | 52.82%-6.28K | ---- | ---- | ---- | -36.92%48.7K | -119.40%-13.3K | 49.18%58.72K | -3.05%323.44K | 88.71%138.33K |
| Operating profit | -73.13%-2.62M | -44.79%-1.96M | -21.55%-1.79M | -3.93%-6.67M | -31.77%-2.33M | -5.28%-1.51M | 13.31%-1.35M | 10.82%-1.47M | 20.95%-6.42M | 26.65%-1.77M |
| Net non-operating interest income (expenses) | -46.60%-920.13K | -104.02%-911.33K | -137.14%-802.81K | -227.07%-2.05M | -202.16%-640.68K | -281.18%-627.64K | -227.58%-446.69K | -194.87%-338.54K | -200.58%-627.86K | -287.48%-212.03K |
| Non-operating interest income | 333.71%2.69K | 2,652.10%29.48K | 661.15%11.5K | -67.72%3.36K | -92.03%156 | -73.80%620 | -63.20%1.07K | -52.30%1.51K | -47.21%10.4K | -56.70%1.96K |
| Non-operating interest expense | 46.89%922.82K | 110.11%940.81K | 139.47%814.31K | 222.27%2.06M | 199.47%640.84K | 276.15%628.26K | 221.50%447.76K | 188.23%340.05K | 179.22%638.26K | 261.21%213.99K |
| Other net income (expenses) | 61.57%-410.22K | -942.29%-263.33K | -373.42%-356.29K | -1,097.36%-1.1M | -71.16%-195.07K | -630.64%-1.07M | 1,874.35%31.26K | 422.58%130.31K | 192.48%110.4K | -5,366.00%-113.97K |
| Gain on sale of security | 69.83%-3.42K | -44.81%17.25K | -102.14%-2.79K | 81.71%154.6K | 103.84%4.38K | -105.65%-11.35K | 1,874.35%31.26K | 372,214.29%130.31K | 8,711.64%85.08K | -5,365.95%-113.97K |
| Special income (charges) | 96.39%-35.62K | ---- | ---- | ---835.68K | --150.56K | ---986.24K | ---- | ---- | --0 | --0 |
| -Less:Restructuring and mergern&acquisition | --0 | ---- | ---- | --986.24K | --0 | --986.24K | ---- | ---- | --0 | --0 |
| -Gain on sale of property,plant,equipment | ---35.62K | ---- | ---- | --150.56K | --150.56K | --0 | ---- | ---- | --0 | ---- |
| Other non-operating income (expenses) | -430.25%-371.18K | ---280.59K | ---353.5K | -1,759.03%-420K | -34,999,900.00%-350K | -16,967.47%-70K | ---- | ---- | 121.38%25.32K | ---1 |
| Income before tax | -23.10%-3.95M | -77.25%-3.13M | -75.43%-2.95M | -41.67%-9.82M | -51.14%-3.17M | -129.15%-3.21M | -4.12%-1.77M | 3.47%-1.68M | 17.90%-6.93M | 15.14%-2.1M |
| Income tax | 0 | 0 | 0 | -87.22%-490.11K | 0 | 0 | -390.17K | -87.20%-99.93K | -7.14%-261.78K | -2.90%-208.39K |
| Earnings from equity interest net of tax | ||||||||||
| Net income | -23.10%-3.95M | -127.52%-3.13M | -86.52%-2.95M | -39.88%-9.33M | -67.83%-3.17M | -129.15%-3.21M | 18.88%-1.38M | 6.34%-1.58M | 18.64%-6.67M | 16.75%-1.89M |
| Net income continuous operations | -23.10%-3.95M | -127.52%-3.13M | -86.52%-2.95M | -39.88%-9.33M | -67.83%-3.17M | -129.15%-3.21M | 18.88%-1.38M | 6.34%-1.58M | 18.64%-6.67M | 16.75%-1.89M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -23.10%-3.95M | -127.52%-3.13M | -86.52%-2.95M | -39.88%-9.33M | -67.83%-3.17M | -129.15%-3.21M | 18.88%-1.38M | 6.34%-1.58M | 18.64%-6.67M | 16.75%-1.89M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | -23.10%-3.95M | -127.52%-3.13M | -86.52%-2.95M | -39.88%-9.33M | -67.83%-3.17M | -129.15%-3.21M | 18.88%-1.38M | 6.34%-1.58M | 18.64%-6.67M | 16.75%-1.89M |
| Diluted earnings per share | 0.00%-0.03 | -100.00%-0.02 | -100.00%-0.02 | -16.67%-0.07 | 0.00%-0.02 | -200.00%-0.03 | 0.00%-0.01 | 50.00%-0.01 | 25.00%-0.06 | 0.00%-0.02 |
| Basic earnings per share | 0.00%-0.03 | -100.00%-0.02 | -100.00%-0.02 | -16.67%-0.07 | 0.00%-0.02 | -200.00%-0.03 | 0.00%-0.01 | 50.00%-0.01 | 25.00%-0.06 | 0.00%-0.02 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.